Shareholder Clash Intensifies Over Tiptree’s Billion-Dollar Divestiture

A contentious battle is unfolding among Tiptree’s investors as the company moves forward with plans to sell its insurance subsidiary Fortegra for $1.65 billion. The escalating conflict has drawn in activist shareholder Veradace Partners, which has formally notified U.S. securities regulators of its opposition to the transaction.

Veradace Partners, holding a 5.1% stake in Tiptree, has declared its intention to vote against the Fortegra sale during the special shareholder meeting scheduled for December 3. The investment firm contends that Tiptree has structured the divestiture in an “unfair manner” and maintains that Fortegra represents the majority of the company’s overall value. Supporting this argument is Fortegra’s financial performance, which shows adjusted net Read more...